GENBGenerate Biomedicines, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 15922
Ticker: GENB
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2026-02-27
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: GENB

Detail

Enriched 2026-08-14 20:47

Market cap: $1,936,838,259.24
Shares outstanding (class): 128,352,436
Shares outstanding (weighted): 128,352,436
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: —
Location: SOMERVILLE, MA
Homepage: https://www.generatebiomedicines.com
Description: Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Market cap and share counts drift.

Funds holding this security

22 funds · 22 positions · $77.09M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
SMALLCAP World Fund Inc SMALLCAP World Fund Inc	—	$45.63M	0.06%	3,650,034 NS	FIGI
JPMorgan Small Cap Growth Fund JPMorgan Trust II	—	$7.46M	0.34%	596,468 NS	FIGI
JPMorgan Small Cap Value Fund JPMorgan Trust II	—	$6.17M	0.54%	493,741 NS	FIGI
JPMorgan U.S. Small Company Fund JPMorgan Trust I	—	$4.89M	0.53%	391,168 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$3.32M	0.03%	265,641 NS	FIGI
JPMorgan Small Cap Blend Fund JPMorgan Trust I	—	$2.41M	0.17%	192,755 NS	FIGI
JPMorgan Small Cap Value Portfolio Brighthouse Funds Trust I	—	$1.64M	0.53%	131,034 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$1.21M	0.00%	96,876 NS	FIGI
LVIP JPMorgan Small Cap Core Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$1.07M	0.53%	85,927 NS	FIGI
VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO Voya Investors Trust	—	$729.2K	0.26%	58,335 NS	FIGI
U.S. Small and Mid Cap Equity Fund AMERICAN FUNDS INSURANCE SERIES	—	$496.4K	0.51%	39,715 NS	FIGI
TIFF MULTI-ASSET FUND TIFF Investment Program	—	$422.2K	0.03%	33,776 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$390.3K	0.00%	31,223 NS	FIGI
SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST	—	$235.5K	0.18%	18,838 NS	FIGI
Health Sciences Trust John Hancock Variable Insurance Trust	—	$227.9K	0.10%	18,234 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERGENB
FIGI_COMPOSITEBBG00X9D0NZ0
FIGI_SHARE_CLASSBBG00X9D0P03
CIK0002100782
ISINUS3709201004
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: Generate Biomedicines is a biotech company developing protein-based therapeutics, so it falls under healthcare biotechnology.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.